129. Kongress der Deutschen Gesellschaft für Innere Medizin
zur Liste
Dr. Manuela Stierl
GlaxoSmithKline GmbH & Co. KG Germany
  • Vortrag Immunogenicity, reactogenicity and safety of a Respiratory Syncytial Virus prefusion F (RSVPreF3) candidate vaccine co-administered with the seasonal quadrivalent influenza vaccine in older adults Speaker
    Datum: 24.04.2023 , Zeit: 10:45 | Thema: Infektiologie
    Details